Literature DB >> 33479857

Intravenous administration of Penicillin results in therapeutic intravitreal levels in chronic postoperative endophthalmitis.

Chloe Thabet1, Chloe C C Gottlieb1,2,3, Bernard R Hurley1,2,3, Guijun Zhang3, Adeel Sherazi4, Jonathan B Angel5,6,7.   

Abstract

IMPORTANCE: The role of systemic antibiotics in the treatment of bacterial endophthalmitis remains controversial. While penicillin is a highly effective antibiotic against bacteria that frequently cause endophthalmitis, the ability of systemically administered Penicillin G to penetrate into the vitreous at adequate therapeutic concentrations has not been studied. Its role in the treatment of endophthalmitis, particularly for bacteria for which it is the antibiotic of choice, therefore remains unknown.
OBJECTIVE: We sought to determine whether intravenous administration of Penicillin G leads to adequate therapeutic concentrations in the vitreous for the treatment of bacterial endophthalmitis. DESIGN AND
SETTING: This study was conducted in an ambulatory setting, at the Ottawa Hospital Eye Institute, a university-affiliated tertiary care center, where a 77-year old gentleman with chronic post-cataract surgery Actinomyces neuii endophathalmitis was treated with intravenous Penicillin G (4 × 106 units every 4 h) and intravitreal ampicillin (5000μg/0.1 m1). MAIN OUTCOMES AND MEASURES: Intravitreal concentration of Penicillin G and ampicillin were obtained at the time of intraocular lens removal, measured by high-performance liquid chromatography.
RESULTS: The intravitreal concentration of penicillin and ampicillin was 3.5μg/ml and 0.3μg/ml, respectively. Both the concentration of penicillin and ampicillin were within the level of detection of their respective assays (penicillin 0.06-5μg/ml, ampicillin 0.12-2.5μg/ml). CONCLUSION AND RELEVANCE: This study shows that intravenous Penicillin G administered every four-hours allows for adequate intravitreal concentrations of penicillin. Future studies are required to determine if the results of this study translate into improved clinical outcomes.

Entities:  

Year:  2021        PMID: 33479857      PMCID: PMC7820044          DOI: 10.1186/s12348-020-00232-0

Source DB:  PubMed          Journal:  J Ophthalmic Inflamm Infect        ISSN: 1869-5760


  14 in total

Review 1.  Antibiotics in endophthalmitis: microbiological and pharmacokinetic considerations.

Authors:  Carmen López-Cabezas; Dolors Soy Muner; Merce Roca Massa; Josep M Mensa Pueyo
Journal:  Curr Clin Pharmacol       Date:  2010-02

2.  Penetration of piperacillin into the vitreous after intravenous administration.

Authors:  A Robinet; M A Le Bot; J Colin; C Riche
Journal:  Retina       Date:  1998       Impact factor: 4.256

Review 3.  Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics.

Authors:  L Brockhaus; D Goldblum; L Eggenschwiler; S Zimmerli; C Marzolini
Journal:  Clin Microbiol Infect       Date:  2019-02-14       Impact factor: 8.067

4.  Human intraocular penetration of sodium oxacillin.

Authors:  R E Records
Journal:  Arch Ophthalmol       Date:  1967-05

5.  Changing trends in the microbiologic aspects of postcataract endophthalmitis.

Authors:  Franco M Recchia; Brandon G Busbee; Robert B Pearlman; Cynthia A Carvalho-Recchia; Allen C Ho
Journal:  Arch Ophthalmol       Date:  2005-03

6.  Antimicrobial susceptibility of clinical isolates of Actinomyces and related genera reveals an unusual clindamycin resistance among Actinomyces urogenitalis strains.

Authors:  Claudia Barberis; Mabel Budia; Susana Palombarani; Carlos Hernán Rodriguez; María Soledad Ramírez; Barbara Arias; Laura Bonofiglio; Angela Famiglietti; Marta Mollerach; Marisa Almuzara; Carlos Vay
Journal:  J Glob Antimicrob Resist       Date:  2017-01-18       Impact factor: 4.035

7.  Ampicillin penetration into the rabbit eye.

Authors:  L Salminen
Journal:  Acta Ophthalmol (Copenh)       Date:  1978-12

8.  Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martin Thiel; Thomas Grasbon; Christopher N Ta; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-24       Impact factor: 3.117

9.  Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1995-12

Review 10.  Pharmacokinetics of intravitreal antibiotics in endophthalmitis.

Authors:  Medikonda Radhika; Kopal Mithal; Abhishek Bawdekar; Vivek Dave; Animesh Jindal; Nidhi Relhan; Thomas Albini; Avinash Pathengay; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.